Mariner Wealth Advisors »

Biomarin Pharmaceutical shares owned by Mariner Wealth Advisors

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Mariner Wealth Advisors from 13F filings

Historical chart of Mariner Wealth Advisors investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Mariner Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Mariner Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $40k 42k 0.95
2022-09-30 $12k 12k 1.00

More positions owned by Mariner Wealth Advisors

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Amazon (AMZN)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core Us Aggbd Et (AGG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Growth Etf (VUG)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Broadcom (AVGO)

View all positions for Mariner Wealth Advisors

Top funds holding Biomarin Pharmaceutical

MacKay Shields
Ing Investment Management
Wellesley Investment Advisors
Lazard Asset Management
Victory Capital Management
Thrivent Financial for Lutherans
Jpmorgan Chase & Co
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
State Street Corporation
Schroder Investment Management Group
Morgan Stanley
Sonora Investment Management Group
Leucadia National Corporation
Franklin Resources
Bank of America Corporation

View all funds holding Biomarin Pharmaceutical